RPN2 and breast cancer: siRNA directed against Ribophorin II (RPN2), which is part of an N-oligosaccharyl transferase complex, were tested by Honma et al. for their ability to promote apoptosis of docetaxel-resistant MCF7-ADR breast cancer cells and were shown to hypersensitized these cells to the chemotherapeutic agent[50].